PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1677757
PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1677757
Anti-Obesity Drugs Market Introduction and Overview
According to SPER Market Research, 'Global Anti-Obesity Drugs Market Size - By Type, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Anti-Obesity Drugs Market is predicted to reach 79.26 billion by 2034 with a CAGR of 27.24%
Anti-obesity drugs are pharmaceutical treatments developed to combat excessive weight gain and the associated health complications, such as diabetes, hypertension, cardiovascular diseases, and certain cancers. These drugs work through various mechanisms, including appetite suppression, enhanced fat metabolism, and reduced calorie absorption, offering a solution for individuals who struggle to lose weight through diet and exercise alone.
Restraints: The market for anti-obesity medications has a number of obstacles in spite of its promise. Accessibility is restricted by the high expense of pharmaceuticals, particularly in low- and middle-income nations. Patients and healthcare professionals are discouraged from widespread adoption by safety concerns, which include side effects including cardiovascular risks or gastrointestinal problems. Critical obstacles include limited long-term efficacy and the considerable risk of weight return following therapy discontinuation.
Scope of the Report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Type, By Distribution Channel.
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
Companies Covered
Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novo Nordisk A/S, Pfizer Inc, Sandoz International GmbH, VIVUS LLC. and others.
Anti-Obesity Drugs Market Segmentation:
By Type: Based on the Type, Global Anti-Obesity Drugs Market is segmented as; Prescription Drugs and OTC Drugs.
By Distribution Channel: Based on the Distribution Channel, Global Anti-Obesity Drugs Market is segmented as; Hospital Pharmacy and Online & Retail Pharmacy.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.